217 Queen Street West
Toronto, ON M5V 0R2
|Mr. James Andre-Charles Lanthier||Chief Exec. Officer||357.8k||37.46k||1975|
|Mr. Arvin Ramos CPA||Chief Financial Officer||87.69k||N/A||1979|
|Mr. Joseph Araujo||Chief Scientific Officer, Member of Scientific Advisory Board & Director||258.72k||N/A||1977|
|Mr. Jason Atkinson||VP of Corp. Devel.||112.44k||N/A||1988|
|Dr. Abdelmalik Slassi Ph.D.||Sr. VP of Innovation & Member of Scientific Advisory Board||352.29k||N/A||N/A|
|Chris Irwin||Corp. Sec.||N/A||N/A||N/A|
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
Mindset Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.